What to Expect From Hologic’s Next Quarterly Earnings Report

With a market cap of $14.7 billion, Hologic, Inc. (HOLX) is a Massachusetts-based medical technology company specializing in women's health. Hologic develops, manufactures, and supplies diagnostic products, medical imaging systems, and surgical devices. Its core business segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. 

HOLX is all geared up for its fiscal Q4 2025 results after the market closes on Wednesday, Nov. 3. Before this event, analysts project this company to report an adjusted EPS of $1.10, up 8.9% from $1.01 in the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in three of the last four quarters, while falling short in one quarter.